Stock SABS SAB BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart SAB Biotherapeutics, Inc.

Equities

SABS

US78397T2024

Delayed Nasdaq
Other stock markets
 04:30:00 2024-06-18 pm EDT 		5-day change 1st Jan Change
2.58 USD -20.62% Intraday chart for SAB Biotherapeutics, Inc. -23.89% -62.47%
Jun. 07 Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target MT
May. 30 SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SAB BIOTHERAPEUTICS, INC.
Bio Therapeutic Drugs
-20.62%-23.89%-62.47%-70.34% - 23.81M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. SABS Stock
  4. Charts SAB Biotherapeutics, Inc.
  5. Comparison Chart